Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Murska Sobota

4 clinical trials in Murska Sobota, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Murska Sobota at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Murska Sobota

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Colitis ulcerative

Not yet recruiting
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Murska Sobota

What the registry says about research in the country

01 Neurodegenerative Disorders

Research focusing on managing behavioral symptoms in Alzheimer's disease, particularly investigating new treatments for agitation in dementia patients. These trials aim to evaluate innovative therapeutic approaches for improving quality of life.

  • Alzheimer's Type Dementia
  • Behavioral Symptoms Management
  • Agitation Treatment

Studies emphasize patient safety and tolerability assessment of new therapeutic compounds.

02 Cardiovascular Research

Innovative clinical trials exploring combination therapies for heart failure patients. Research focuses on testing new drug combinations with empagliflozin to improve cardiovascular outcomes and reduce hospitalization rates.

  • Heart Failure Management
  • Combination Therapy
  • Cardiovascular Mortality

Studies target patients with specific ejection fraction parameters to optimize treatment approaches.

03 Inflammatory Bowel Diseases

Comprehensive research into treatments for inflammatory bowel conditions, including studies on both Ulcerative Colitis and Crohn's Disease. Trials evaluate new targeted therapies and biological treatments.

  • Ulcerative Colitis
  • Crohn's Disease
  • Novel Biological Therapies

Focus on comparing effectiveness of new compounds with established treatments for moderate to severe cases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).